We’ll be observing Martin Luther King Jr. Day on Monday, January 18 in the US so GHN will not be publishing. We’ll be back Tuesday with more news. 

Editor’s Note: This is the first of an occasional GHN series examining the health challenges that the new Biden administration must confront in its first 100 days.   The incoming Biden administration promises a vigorous, across-the-board reboot of the failed US…

A Chinese-made coronavirus vaccine has an efficacy rate just over 50%—far lower than the 78% anticipated, according to a Brazilian clinical trial conducted by São Paulo’s Butantan Institute.  

WHO investigators from 9 countries have arrived in Wuhan to look into the origins of the pandemic, following delays that triggered a rare rebuke from the agency.  

One Friday last month, I posted a map on Twitter. It drew immediate global attention, was seen by 8 million people, and has provoked strong responses and anger—and hopefully some soul-searching among those in governments and pharmaceutical companies.

For many detainees in US immigration facilities, the coronavirus was impossible to avoid. They were sleeping 3 feet apart with 36 people in a room.

“The virus took Grandma Delores first, silencing an 86-year-old voice that rang with Lakota songs and stories.”  

Among the many challenges facing President-elect Joe Biden upon his inauguration on January 20, the most urgent is the US COVID-19 response. How will things change? What will be his strategies and priorities?

Infectious new coronavirus variants spell bad news for already-strained hospitals, the WHO said yesterday,